Pauza Charles David has filed 7 insider transactions across 1 company since April 2024.
Most recent transaction: a grant/award of 118367 shares of Traws Pharma, Inc. ($TRAW) on March 08, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 8, 2026 | Traws Pharma, Inc. | $TRAW | Pauza Charles David | Chief Science Officer Virology | A | Stock Option (right to buy) | 118367 | $0.00 | 118,367.0000 | 8,818,859 | 9999.99% | 1.34% |
| Dec. 12, 2025 | Traws Pharma, Inc. | $TRAW | Pauza Charles David | Chief Science Officer Virology | A | Common Stock | 18471 | $0.00 | 115,971.0000 | 8,818,859 | 18.94% | 0.21% |
| Dec. 12, 2025 | Traws Pharma, Inc. | $TRAW | Pauza Charles David | Chief Science Officer Virology | A | Stock Option (right to purchase) | 73886 | $0.00 | 73,886.0000 | 8,818,859 | 9999.99% | 0.84% |
| Oct. 12, 2025 | Traws Pharma, Inc. | $TRAW | Pauza Charles David | Chief Science Officer Virology | A | Stock Option (right to purchase) | 32406 | $0.00 | 32,406.0000 | 8,818,859 | 9999.99% | 0.37% |
| April 1, 2024 | Traws Pharma, Inc. | $TRAW | Pauza Charles David | Chief Science Officer Virology | A | Common Stock | 97500 | $0.00 | 97,500.0000 | 841,738 | 9999.99% | 11.58% |
| April 1, 2024 | Traws Pharma, Inc. | $TRAW | Pauza Charles David | Chief Science Officer Virology | A | Stock Option (right to purchase) | 503227 | $0.00 | 503,227.0000 | 841,738 | 9999.99% | 59.78% |
| April 1, 2024 | Traws Pharma, Inc. | $TRAW | Pauza Charles David | Chief Science Officer Virology | A | Stock Option (right to purchase) | 333136 | $0.00 | 333,136.0000 | 841,738 | 9999.99% | 39.58% |